NCT Number: NCT00986271
Extravascular Lung Water Index in Severe Sepsis
To investigate whether extravascular lung water index (EVLI) is an independent predictor for multiorgan dysfunction syndrome (MODS) in patients with severe sepsis and to determine if increased EVLI may serve as an predictor for MODS and mortality in those patients.
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- All enrolled patients were recruited consecutively on the day of MICU admission and within 24 hours of the diagnosis of severe sepsis.
Exclusion criteria
- Pregnancy,
- Age less than 18 years old, and
- Uncontrolled malignancy.
Treatment and study plan
Primary outcomes
-
Developement of MODS (multiorgan dysfunction syndrome) and mortality
Sponsors and collaborators
Lead sponsor
Chang Gung Memorial Hospital
Other
Registry information
Acronym: EVLI in sepsis
Important dates
- First posted
- Sep 29, 2009
- Registry last updated
- Sep 29, 2009
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Zinc Therapy in Critical Illness
NCT01162109
Critical Illness, Disease Attributes
Burlington, Vermont, United States
View Trial DetailsGM-CSF to Decrease ICU Acquired Infections
NCT02361528
Infections, Inflammation
Amiens, France
View Trial DetailsDe-escalation of Empirical Antimicrobial Therapy Study in Severe Sepsis
NCT01626612
Infections, Inflammation
Marseille, France
View Trial DetailsEndothelium in Severe Sepsis
NCT00793442
Infections, Inflammation
Birmingham, Alabama, United States
View Trial Details